|
|
 |
| |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Out Licensing
|
|
Cooper Pharma Strategy
In the context of globalization, Cooper Pharma focuses a part of its strategy on the international market, thus considering export as a vector of development and competitiveness.
Cooper Pharma has adapted its internal organization in order to create and maintain a synergy between its In- licensing and Out-licensing activities. Cooper Pharma, with its regional experience, can benefit its partners with a broad distribution network deeply rooted in several countries in Sub-Saharan Africa, Maghreb and the Middle East.
Our strategy is based on:
-
Permanent upgrade of the manufacturing facilities
-
Adaptation of products and services (marketing and medical support, product portfolio) to foreign markets
-
Registration of the regulatory dossier according to both European and local requirements
-
Commercial reactivity
-
Development of our own sales force in several African countries
Current export countries or subsidiaries
|
Europe
|
• Danemark
• Norway
• Czech Republic
• Slovakia
|
|
Subsaharian Africa
|
• Benin / Burkina Faso / Burundi
• Cameroon / Central Afrique / Congo / Côte d'Ivoire
• Djibouti / Gabon / Ghana / Guinea
• Maurice Island / Madagascar / Mali / Niger
• Congo D.R. / Rwanda / Senegal
|
|
North Afrique
|
|
Deals in process
|
Europe
|
• France
• Eastern Europe
|
|
Middle East
|
• Kingdom of Saudi Arabia
• Kuwait / Lebanon / Yemen
• United Arab Emirates
|
|
North America
|
• Canada
|
|
South America
|
• Mexique / Chile
|
Our projects
Opening of a scientific office in Romania.
|
|
|
|
|
|
|
| © 2007-2010 Cooper Pharma - Created and maintained by WSI
|
|
|
|
|
|